Amoxicillin And Clavulanate Potassium Suspension
Product Images NDC 69097-098

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Amoxicillin And Clavulanate Potassium (NDC 69097-098). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Amoxicillin And Clavulanate Potassium Oral Suspension 100ml Bottle Label)

Image Description (Amoxicillin And Clavulanate Potassium Oral Suspension 100ml Bottle Label)
Label for Amoxicillin and Clavulanate Potassium Oral Suspension USP, 250 mg/62.5 mg per 5 mL, by Cipla USA Inc. The label includes dosing reconstitution instructions, storage conditions, and manufacturer information. The product is a 100 mL suspension when reconstituted and requires refrigeration. Barcode and expiration date (08/2024) are visible.*
FDA Label Image

Image Description (Amoxicillin And Clavulanate Potassium Oral Suspension 150ml Bottle Label)

Image Description (Amoxicillin And Clavulanate Potassium Oral Suspension 150ml Bottle Label)
Label for Amoxicillin and Clavulanate Potassium oral suspension, USP, 250 mg/62.5 mg per 5 mL, manufactured by Cipla USA Inc. The label provides mixing instructions, storage requirements (store powder at 20°-25°C, must be refrigerated after reconstitution), and package size (150 mL when reconstituted). It includes the NDC 69097-098-08 and barcode.*
FDA Label Image

Image Description (Amoxicillin And Clavulanate Potassium Oral Suspension 75ml Bottle Label)

Image Description (Amoxicillin And Clavulanate Potassium Oral Suspension 75ml Bottle Label)
Label for Amoxicillin and Clavulanate Potassium Oral Suspension, USP 250 mg/62.5 mg per 5 mL by Cipla USA Inc. The label includes preparation and storage instructions, mixing directions, and net content details for a 75 mL suspension when reconstituted. It shows the NDC number 69097-098-43 and a barcode on the right side.*
FDA Label Image

Image Description (Amoxicillin And Clavulanate Potassium Structure 1)

Image Description (Amoxicillin And Clavulanate Potassium Structure 1)
Chemical structure of Amoxicillin and Clavulanate Potassium showing its molecular framework including phenol, beta-lactam ring, and other functional groups. The structure also indicates the presence of a trihydrate form.*
FDA Label Image

Image Description (Amoxicillin And Clavulanate Potassium Structure 2)

Image Description (Amoxicillin And Clavulanate Potassium Structure 2)
Chemical structure diagram of Amoxicillin and Clavulanate Potassium, showing the core bicyclic ring with attached functional groups including a carboxylate (COOK), aldehyde (CH2OH), and lactam moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.